Published in Carcinogenesis on April 09, 2016
Targeting Inflammation in Cancer Prevention and Therapy. Cancer Prev Res (Phila) (2016) 0.78
Chemopreventive Strategies for Inflammation-Related Carcinogenesis: Current Status and Future Direction. Int J Mol Sci (2017) 0.75
Mechanisms of colitis-accelerated colon carcinogenesis and its prevention with the combination of aspirin and curcumin: Transcriptomic analysis using RNA-seq. Biochem Pharmacol (2017) 0.75
The history of cancer epigenetics. Nat Rev Cancer (2004) 14.38
A unique chromatin signature uncovers early developmental enhancers in humans. Nature (2010) 14.02
IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell (2009) 11.52
Histone acetylation and transcriptional regulatory mechanisms. Genes Dev (1998) 10.16
Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. N Engl J Med (2007) 9.04
Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. Lancet (2011) 6.77
Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials. Lancet Oncol (2012) 3.37
Dextran sodium sulphate colitis mouse model: traps and tricks. J Biomed Biotechnol (2012) 2.97
Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin. Dig Dis Sci (1993) 2.62
The AOM/DSS murine model for the study of colon carcinogenesis: From pathways to diagnosis and therapy studies. J Carcinog (2011) 2.30
Histone hyperacetylation is associated with amelioration of experimental colitis in mice. J Immunol (2006) 2.09
Estimation of liver tumor volume using different formulas - an experimental study in rats. J Cancer Res Clin Oncol (1983) 1.91
Suppression of experimental colitis by intestinal mononuclear phagocytes. J Leukoc Biol (2006) 1.90
Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies. Anticancer Res (2009) 1.82
Nitric oxide and TNF-alpha trigger colonic inflammation and carcinogenesis in Helicobacter hepaticus-infected, Rag2-deficient mice. Proc Natl Acad Sci U S A (2009) 1.81
The risk of cancer in patients with Crohn's disease. Dis Colon Rectum (2007) 1.80
Predictive and protective factors associated with colorectal cancer in ulcerative colitis: A case-control study. Gastroenterology (2006) 1.51
Epigenetic regulation of tumor necrosis factor alpha. Mol Cell Biol (2007) 1.46
A gamma-tocopherol-rich mixture of tocopherols inhibits colon inflammation and carcinogenesis in azoxymethane and dextran sulfate sodium-treated mice. Cancer Prev Res (Phila) (2009) 1.27
Azacitidine. Nat Rev Drug Discov (2005) 1.23
Histone deacetylases and the immunological network: implications in cancer and inflammation. Oncogene (2009) 1.23
Inflammation, DNA methylation and colitis-associated cancer. Carcinogenesis (2012) 1.20
Tumor formation in a mouse model of colitis-associated colon cancer does not require COX-1 or COX-2 expression. Carcinogenesis (2010) 1.15
Histone deacetylases augment cytokine induction of the iNOS gene. J Am Soc Nephrol (2002) 1.13
Histone deacetylases: novel targets for prevention of colitis-associated cancer in mice. Gut (2008) 1.13
Over-expression of COX-2 mRNA in colorectal cancer. BMC Gastroenterol (2014) 1.06
Aspirin for the prevention of colorectal cancer. Best Pract Res Clin Gastroenterol (2011) 0.96
Aspirin acetylates multiple cellular proteins in HCT-116 colon cancer cells: Identification of novel targets. Int J Oncol (2011) 0.95
Histone modifications as a pathogenic mechanism of colorectal tumorigenesis. Int J Biochem Cell Biol (2012) 0.94
DNA methylation profiles in precancerous tissue and cancers: carcinogenetic risk estimation and prognostication based on DNA methylation status. Epigenomics (2010) 0.92
Aspirin, cyclooxygenase inhibition and colorectal cancer. World J Gastrointest Pharmacol Ther (2014) 0.92
Inhibition of histone deacetylases in inflammatory bowel diseases. Mol Med (2011) 0.89
Aspirin may promote mitochondrial biogenesis via the production of hydrogen peroxide and the induction of Sirtuin1/PGC-1α genes. Eur J Pharmacol (2012) 0.86
Aspirin-induced histone acetylation in endothelial cells enhances synthesis of the secreted isoform of netrin-1 thus inhibiting monocyte vascular infiltration. Br J Pharmacol (2015) 0.85
Differential patterns of histone acetylation in inflammatory bowel diseases. J Inflamm (Lond) (2011) 0.84
Histone H3 lysine 27 acetylation is altered in colon cancer. Clin Proteomics (2014) 0.84
Aspirin promotes apoptosis in a murine model of colorectal cancer by mechanisms involving downregulation of IL-6-STAT3 signaling pathway. Int J Colorectal Dis (2010) 0.83
Epigenetic regulation of inflammatory gene expression in macrophages by selenium. J Nutr Biochem (2014) 0.82
In vitro and in vivo anti-inflammatory effects of a novel 4,6-bis ((E)-4-hydroxy-3-methoxystyryl)-1-phenethylpyrimidine-2(1H)-thione. Chem Res Toxicol (2013) 0.81
The role of alcohol dehydrogenase in the metabolism of the colon carcinogen methylazoxymethanol. Toxicol Sci (1998) 0.81
Epigenetic clustering of gastric carcinomas based on DNA methylation profiles at the precancerous stage: its correlation with tumor aggressiveness and patient outcome. Carcinogenesis (2015) 0.81
Chromatin remodelling and autocrine TNFα are required for optimal interleukin-6 expression in activated human neutrophils. Nat Commun (2015) 0.81
Chronic aspirin use suppresses CDH1 methylation in human gastric mucosa. Dig Dis Sci (2009) 0.80
Chromatin profiling reveals regulatory network shifts and a protective role for hepatocyte nuclear factor 4α during colitis. Mol Cell Biol (2014) 0.80
Curcumin inhibits anchorage-independent growth of HT29 human colon cancer cells by targeting epigenetic restoration of the tumor suppressor gene DLEC1. Biochem Pharmacol (2015) 0.80
Histone deacetylase inhibitors and colorectal cancer: what is new? Anticancer Agents Med Chem (2014) 0.79
Targeting epigenetic mechanisms and microRNAs by aspirin and other non steroidal anti-inflammatory agents--implications for cancer treatment and chemoprevention. Cell Oncol (Dordr) (2014) 0.79
Current Perspectives on Epigenetic Modifications by Dietary Chemopreventive and Herbal Phytochemicals. Curr Pharmacol Rep (2015) 0.78